Evidence map›Paper›PMID 32219077›Full record

ArticleIranian journal of otorhinolaryngology2020

Giant Thyroid Fibrosarcoma- A Case Report.

Manuel Tucciarone, Carlos Heredia-Llinas, Alejandro Lowy-Benoliel, Rosalia Souviron-Encabo, Tomas Martínez-Guirado, Ricardo González-Orus Álvarez-Morujo

Open access · greenAbstract readCase Reports
In one paragraph

Article in Iranian journal of otorhinolaryngology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Manuel TucciaroneDepartment of Otorhinolaryngology, Gregorio Marañón Hospital, Madrid, SPAIN.
Carlos Heredia-LlinasDepartment of Otorhinolaryngology, Gregorio Marañón Hospital, Madrid, SPAIN.
Alejandro Lowy-BenolielDepartment of Otorhinolaryngology, Gregorio Marañón Hospital, Madrid, SPAIN.
Rosalia Souviron-EncaboDepartment of Otorhinolaryngology, Gregorio Marañón Hospital, Madrid, SPAIN.
Tomas Martínez-GuiradoDepartment of Otorhinolaryngology, Gregorio Marañón Hospital, Madrid, SPAIN.
Ricardo González-Orus Álvarez-MorujoDepartment of Otorhinolaryngology, Gregorio Marañón Hospital, Madrid, SPAIN.
Hospital General Universitario Gregorio Marañón · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThyroid gland fibrosarcomas are extremely rare tumors, and only very few cases have been described in the literature. There are no set recommendations along with follow-ups regarding the treatment of these tumors. Moreover, the prognosis is poor with a very short life expectancy. CASE REPORT: We present an 81-year-old patient who was suffering from increasing dysphagia and dysphonia related to a painless giant cervical mass, which presented with progressive growth for the preceding months. After a core needle biopsy with a suspicion of a solitary fibrous tumor, total excision of the tumor was successfully performed, and the pathology examination revealed a fibrosarcoma. Following surgery, radiotherapy was decided in the oncological multidisciplinary meeting; however, the patient refused it. There were neither new clinical symptoms nor tumor recurrence after an 18-month follow-up.

conclusionAlthough it is a very rare tumor, primary fibrosarcoma of the thyroid gland should be kept in mind in the differential diagnosis of neck tumors.

Indexed as

FibrosarcomaHead and NeckHead and Neck CancerNeoplasmThyroid cancer

Identifiers

PMID32219077
PMCPMC7085927
OpenAlexW3005954836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.